Citigroup’s Tenon Medical TNON Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$564 Sell
49
-233
-83% -$5.59K ﹤0.01% 5454
2026
Q1
$7.15K Buy
+282
New +$8.3K ﹤0.01% 5156
2025
Q4
– Sell
-1
Closed -$40 – 5993
2025
Q3
$51 Buy
+1
New +$42 ﹤0.01% 5851
2025
Q2
– Sell
-3
Closed -$253 – 5904
2025
Q1
$253 Buy
+3
New +$169 ﹤0.01% 5408
2024
Q4
– Hold
0
– -$4 – 5959
2024
Q3
– Hold
0
– – – 5640
2024
Q2
– Hold
0
– – – 5552
2024
Q1
– Hold
0
– – – 5607
2023
Q4
– Hold
0
– – – 5663
2023
Q3
– Hold
0
– – – 5648
2023
Q2
– Hold
0
– – – 5548
2023
Q1
– Hold
0
– – – 5287
2022
Q4
– Hold
0
– – – 5645
2022
Q3
– Sell
-1
Closed -$5.83K – 6319
2022
Q2
$3K Buy
+1
New +$29.1K ﹤0.01% 5804

Other funds holding TNON

Citigroup's TNON Position: Q2 2026 in Review

Citigroup reduced its Tenon Medical (TNON) stake by 83% in Q2 2026, selling an estimated $5.59K and leaving 49 shares worth $564. The position accounts for ﹤0.01% of the portfolio, ranked #5454.

Citigroup first reported a position in TNON in Q2 2022 and has held it in 5 quarters since. The position peaked at $7.15K in Q1 2026. 16 funds tracked by Wall St. Rank hold TNON as of Q2 2026.

  • Citigroup held 49 shares of Tenon Medical worth $564 as of Q2 2026.
  • Citigroup sold 233 Tenon Medical shares in Q2 2026, an estimated $5.59K.
  • Tenon Medical made up ﹤0.01% of Citigroup's portfolio in Q2 2026, its #5454 holding.
  • Citigroup first reported a position in Tenon Medical in Q2 2022 and has held it in 5 quarters since.
  • Citigroup's Tenon Medical position peaked at $7.15K in Q1 2026.
  • 16 funds tracked by Wall St. Rank held Tenon Medical as of Q2 2026.

Based on Citigroup's 13F filing for Q2 2026, filed 3 Aug 2026.